Oculodentodigital dysplasia, a rare condition displaying congenital craniofacial deformities and limb abnormalities, has been associated with over 20 known human connexin43 (Cx43) mutations. The localization of two of these mutants, G21R and G138R, was examined in Cx43-positive normal rat kidney cells (NRK) and Cx43-negative gap junctional intercellular communication-deficient HeLa cells. Green fluorescent protein-tagged and untagged Cx43 G21R and G138R mutants were transported to the plasma membrane and formed punctate structures reminiscent of gap junction plaques in both NRK and HeLa cells. Further localization studies revealed no significant trafficking defects as subpopulations of Cx43 mutants were found in both the Golgi apparatus and lysosomes, not unlike wild-type Cx43. Dual patch clamp functional analysis of the mutants expressed in gap junctional intercellular communication-deficient N2A cells revealed that neither G21R nor G138R formed functional gap junction channels, although they successfully reached cell-cell interfaces between cell pairs. Importantly, when either mutant was expressed in NRK cells, dye coupling experiments revealed that both mutants inhibited endogenous Cx43 function. These studies suggest that, although patients suffering from oculodentodigital dysplasia possess one wild-type Cx43 allele, it is likely that Cx43-mediated gap junctional intercellular communication is reduced below 50% because of a dominant-negative effect of mutant Cx43 on wild-type Cx43.
Gap junctions are protein intercellular channels that link adjacent cells to allow for the exchange of small ions and molecules less than 1 kDa in size (1) . Protein constituents of gap junctions, connexins, oligomerize to form hemichannels that dock with symmetrical connexin arrangements from the adjacent cell to form gap junction channels. At the cell surface, hundreds of gap junction channels cluster to form gap junction plaques (2) . The molecular arrangement of a connexin consists of four transmembrane regions with both the amino-and carboxyl-terminal domains exposed to the cytosol, two extracellular loops, and one intracellular loop (2) (3) (4) . This polytopic topology of connexins, including connexin43 (Cx43), 1 is established during co-translational insertion into the endoplasmic reticulum (5) .
There are at least 21 unique connexins expressed in the human genome (6, 7) . Because many cells express more than one connexin isoform, they can combine to form both homomeric and heteromeric hemichannels as well as both homotypic and heterotypic intercellular gap junction channels (8) . This diversity of combinations defines the nature of gap junctional intercellular communication (GJIC), which in turn regulates many important physiological and developmental processes (2) .
Connexin mutations are linked to several human diseases. Many mutations in Cx32 are associated with the peripheral neuropathy known as Charcot-Marie-Tooth X-linked disease (9) . Mutations in Cx26 account for roughly half of all cases of inherited non-syndromic deafness (10) , and many of these mutations are associated with skin diseases (11, 12) . In addition, in the lens, mutations in both Cx46 and Cx50 are linked to cataracts (13) . The first human disease found to be linked to germ line Cx43 mutations was oculodentodigital dysplasia (ODDD) (14, 15) . ODDD is a rare autosomal-dominant human disorder in which patients display symptoms of congenital craniofacial deformities and limb abnormalities (14) . Digital malformations include syndactyly involving the third, fourth, and fifth fingers and camptodactyly of the second to fourth toes (15) . Neurological symptoms are also frequent in this disorder with evidence of mild mental retardation (16) . To date, over 70 reports of the clinical features of ODDD in over 240 patients have been described (16) .
The ODDD locus was mapped to chromosome 6q22-q24 by linkage analysis (14) , and location of the disease gene was further refined between D6S261 and D6S1639 markers (17) . Paznekas et al. (15) report that GJA1, the gene encoding the gap junction protein Cx43, was responsible for the pleiotropic condition ODDD because of its map location. These authors have further confirmed mutations in 100% of studied individuals who are affected with ODDD (15) . To date, there are over 20 known Cx43 mutations linked to ODDD that result in the introduction of a mutation change in the first two-thirds of the Cx43 amino acid sequence (15, 18) .
The purpose of this study was to characterize the distribution and functional properties of two of these mutants, G21R and G138R, which show a non-conservative amino acid change from a neutral glycine to a charged arginine (Fig. 1) . G21R is predicted to be located within the first transmembrane domain, which is considered to be an important motif for connexin insertion into the membrane (19, 20) . G138R is located within the intracellular loop, which has been shown to have gating function as proposed by the "ball and chain" model of channel regulation in which the carboxyl tail acts as a gating particle that interacts with the "receptor" encoded within the intracellular loop (21) (22) (23) . It was the purpose of this study to examine the functional properties of select Cx43 disease-linked mutants, G21R or G138R, in an attempt to provide insight into the pathophysiology underlying the ODDD condition.
EXPERIMENTAL PROCEDURES
Cells and Reagents-All culture media and reagents were obtained from Invitrogen. Normal rat kidney (NRK), mouse neuroblastoma (N2A), and human cervical carcinoma HeLa cells were cultured in regular high glucose Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine (except N2A cells), 100 units/ml penicillin, and 100 g/ml streptomycin. All cells were purchased from the American Type Culture Collection (Manassas, VA) and were maintained at 37°C in a moist environment of 95% air and 5% CO 2 and subcultured as required.
DNA Constructs and Transfection-Two Cx43 mutants (underline indicates nucleotide change in the following sequences) were constructed using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) as directed. The G21R mutation was made by changing the nucleotide G to A at position 61. The G138R mutation was made by changing the G to A at position 412 and the T to G at position 414. The primer sequences used to generate the G21R mutation were forward 5Ј-GCCTACTCAACTGCTAGAGGGAAGGTGTGGCTG-3Ј and reverse 5Ј-CAGCCACACCTTCCCTCTAGCAGTTGAGTAGGC-3Ј. The primer sequences used to generate the G138R mutation were forward 5Ј-GAAGTTCAAGTACAGGATTGAAGAGCATGG-3Ј and reverse 5Ј-CCATGCTCTTCAATCCTGTACTTGAACTTC-3Ј. Following sequence verification, the wild-type Cx43, G21R, and G138R were cloned into the BamH1 and HindIII restriction sites of the pcDNA 3.1 vector (Invitrogen). Cx43, G21R, and G138R cDNAs were also cloned into the pEGFP-N1 vector (BD Biosciences, Clontech, La Jolla, CA), using the BamH1 and KpnI restriction sites. The GFP tag was fused to the carboxyl-terminal of wild-type Cx43, G21R, and G138R after removal of the stop codon. The PCR primers used to engineer GFP-tagged constructs consisted of forward 5Ј-CGGGGTACCAACATGGGTGACTGGAGC-3Ј and reverse 5Ј-CGCGGATCCTTGATCTCCAGGTCATCAG-3Ј. DNA sequencing was performed by the Robarts Research Institute DNA Sequencing Facility (London, ON, Canada) using an Applied Biosystems 3730 analyzer and compared with human Cx43 sequences available from NCBI.
HeLa, NRK, and N2A cells were grown to 50 -75% confluency in 60-mm culture dishes and transfected at 37°C in Opti-MEM medium (Invitrogen) containing Lipofectamine 2000 and 1-2 g of plasmid cDNA. After 5 h, DNA/Lipofectamine suspension was removed and replaced with culture medium. Transfection efficiency was determined 24 -48 h later by visualizing live or fixed cells under a fluorescence microscope.
Immunofluorescent Labeling and Imaging-Following transient transfections with wild-type or mutant DNA plasmid, cells grown on 12-mm coverslips were fixed in ice-cold 80% methanol and 20% acetone solution for 10 min at 4°C and then rinsed with phosphate-buffered saline and prepared for immunolabeling as previously described (24) . Briefly, cells were blocked with 2% bovine serum albumin in phosphatebuffered saline, immunolabeled with primary antibody, washed with phosphate-buffered saline, and immunolabeled with appropriate secondary antibody. Cells were washed in phosphate-buffered saline and Immunofluorescently labeled cells were imaged on a Zeiss (Thornwood, NY) LSM 510 META confocal microscope mounted on an inverted Axiovert 200 motorized microscope equipped with a ϫ63 oil (1.4 numerical aperture) objective. Fluorescent signals were imaged after excitation with 488, 543, or 730 nm laser lines produced by argon, heliumneon, or tunable Chameleon multiphoton lasers, respectively. All fluorescent signals were collected on a photomultiplier after a passage through appropriate filter sets. Digital images were prepared using Zeiss LSM, Adobe Photoshop 7.0, and CorelDraw software.
Western Blotting and Densitometry-Lysates of NRK cells collected 48 h after transient transfection with 1 g of cDNA encoding Cx43-GFP or GFP-tagged mutants were subjected to Western blotting as we have previously described (24) . Blots were immunolabeled for Cx43 using an anti-Cx43 monoclonal antibody, Cx43NT-1 (1:500; Fred Hutchinson Cancer Research Center Antibody Development Group, Seattle, WA). To estimate the ratio of GFP-tagged Cx43 and mutants to endogenous Cx43, unsaturated blots were scanned and densitometry was performed using Kodak Digital Science 1D 2.0 software to determine the total band intensities of both GFP-tagged and untagged Cx43. The ratio of GFP-tagged Cx43 and mutants to endogenous Cx43 was corrected for transfection efficiency, which was determined by counting all cells in five random fields of 92167 m 2 and calculating the percentage of cells exhibiting GFP fluorescence.
Patch Clamp Electrophysiology-Functional gap junctional coupling between paired N2A cells expressing human Cx43-GFP, G21R-GFP, or FIG. 1. Schematic diagram of Cx43 denoting the amino acid locations of ODDD-linked mutations. The G21R mutation is predicted to be within the first transmembrane domain, and the G138R mutation is expected to be located within the intracellular loop. GFP was linked to the carboxyl-terminal of Cx43 by a seven-amino acid linker sequence.
G138R-GFP was assessed using the dual whole-cell voltage clamp technique (25) . The cells were constantly perfused in an external solution containing 140 mM NaCl, 5 mM KCl, 2 mM CsCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 5 mM Hepes, 5 mM D-glucose, 2 mM pyruvate, and 1 mM BaCl 2 , pH 7.4. Individual N2A cell pairs with obvious green fluorescent plaque(s) located at the junctions between the two cells were selected for recording. Junctional current was measured between cell pairs by using the dual whole-cell voltage-clamp technique with Axopatch 200B patch clamp amplifiers (Axon Instruments Inc., Union City, CA) at room temperature (22-25°C). Recording patch pipettes were prepared with a puller (PP-83; Narishige Scientific Instrument, Tokyo, Japan). The patch pipette had a resistance of 3-5 M⍀ when filled with an internal solution containing 130 mM CsCl, 10 mM EGTA, 0.5 mM CaCl 2 , 3 mM MgATP, 2 mM Na 2 ATP, and 10 mM Hepes, pH 7.2, with CsOH.
Data were filtered at 2 kHz and were acquired using pClamp9 software (Axon Instruments Inc.) and digitized at a 5-10 kHz sampling rate. Each cell of a pair was initially held at a common holding potential of 0 mV. To evaluate junctional coupling, 300-ms hyperpolarizing pulses from the holding potential of 0 to Ϫ20 mV were applied to one cell to establish a transjunctional voltage gradient (V j ), and the junctional current was measured in the second cell. Macroscopic junctional conductance (g j ) was calculated, g j ϭ I j /V j , where I j is the measured junctional current and V j is transjunctional voltage. The experimenter was blind to the connexin subtypes when performing the patch clamp experiments.
Microinjection-NRK cells transiently transfected with cDNA encoding Cx43-GFP, G21R-GFP, or G138R-GFP were selected for microinjection. One cell within a cluster of NRK cells expressing the GFP-tagged
FIG. 2. Cx43 mutants assemble into structures reminiscent of gap junctions at cell-cell interfaces of NRK cells. NRK cells were transfected with cDNAs encoding human Cx43-GFP, G21R-GFP, or G138R-GFP (B-D)
. Transfected cells were fixed and immunolabeled for a constituent resident protein of the Golgi apparatus (TGN38). Similar to the endogenous expression of Cx43 in NRK cells as revealed by immunolabeling (A), wild-type Cx43 (B) and both G21R (C) and G138R (D) mutants localize to the cell surface and appear to form typical gap junction plaques (arrows). Bars ϭ 10 m.
FIG. 3. Cx43 mutants exhibit intracellular localization patterns similar to Cx43-GFP in GJIC-deficient HeLa cells.
HeLa cells were transfected with cDNAs encoding human Cx43-GFP, G21R-GFP, or G138R-GFP, fixed, and immunolabeled for the lysosomal protein LAMP-2 or a constituent resident protein of the Golgi apparatus (giantin). Similar to Cx43-GFP (A and D), both G21R-GFP (B and E) and G138R-GFP (C and F) were localized to the cell surface with profiles typical of gap junctions (arrows). A subpopulation of wild-type and mutant Cx43 localized to lysosomes and the Golgi apparatus (A-F, note yellow color). Small images represent the localization of Cx43, Cx43 mutants, and resident organelle proteins in gray scale (A 1,2--F 1,2 ) . Untagged wild-type (G, green) G21R (H, green), and G138R (I, green) Cx43 were localized to the cell surface with distribution profiles similar to their GFP-tagged counterparts. Nuclei were stained with Hoechst 33342 (G-I, blue) . Bars ϭ 10 m.
protein was pressure microinjected with 1% Lucifer yellow in 0.15 M LiCl (Molecular Probes) until the cell was brightly fluorescent (Ͻ5 s) using an Eppendorf FemtoJet automated pressure microinjector. After 1 min, the percent of microinjected cells that transferred Lucifer yellow to at least one contacting cell was determined using a Leica DM IRE2 inverted epifluorescent microscope. In the case of cells expressing wildtype Cx43-GFP, dye transfer always spread to more than three cells. Digital images were collected with a charged coupled device camera (Hamamatsu Photonics, Japan) using OpenLab software (distributed by Quorum Technologies, Inc., Guelph, ON). As an internal control for every population of cells being assessed, NRK cells that did not express GFP-tagged Cx43 or Cx43 mutants were microinjected with Lucifer yellow as described above to ensure that the population of NRK cells remained functionally coupled during the experimental procedure. At least 30 microinjections were performed for each experimental condition.
RESULTS

Cx43 Mutants Are Transported to, and Cluster at, the Cell Surface in the Presence or Absence of Endogenous Cx43-To
determine the localization patterns of G21R and G138R Cx43 mutants, cDNA constructs were engineered where wild-type and Cx43 mutants were tagged with GFP ( Fig. 1) and expressed in NRK and HeLa cells. GJIC-competent NRK cells, which express endogenous Cx43, were chosen to approximate the ODDD condition, where patients have one wild-type and one mutant Cx43 allele and thus are expected to co-express both wild-type and mutant Cx43. Exogenous wild-type and mutant Cx43 were readily identifiable by the covalently tagged GFP moiety. Confocal microscopy revealed that Cx43-GFP, G21R-GFP, and G138R-GFP were all transported to the cell surface when expressed in NRK cells and formed structures consistent with the appearance of gap junction plaques (Fig. 2, B-D) , similar to that of endogenous Cx43 (Fig. 2A) . Likewise, when Cx43-GFP, G21R-GFP, and G138R-GFP were expressed in GJIC-deficient and Cx43-negative HeLa cells, both wild-type and mutants were transported to the cell surface and formed structures reminiscent of gap junctions (Fig. 3, A-F) . Additionally, an enrichment of intracellular structures that displayed inclusion body-like profiles was exhibited in HeLa cells expressing GFP-tagged Cx43 and mutants (Fig. 3) . Untagged wild-type and mutant Cx43 exhibited similar distribution patterns as the GFP-tagged connexins (Fig. 3, G-I) , reducing the possibility that GFP was significantly altering connexin trafficking.
To identify the intracellular compartments containing Cx43 mutants, NRK and HeLa cells expressing the mutants were immunolabeled with antibodies specific for resident proteins of the Golgi apparatus and lysosomes. Because Cx43 and the mutants were readily transported to the cell surface in NRK cells, no significant population of wild-type Cx43 or mutants co-localized with the resident Golgi protein, TGN-38 (Fig. 2,  B-D) , or with the endoplasmic reticulum resident, protein disulfide isomerase (data not shown). However, in HeLa cells, a subpopulation of wild-type and mutant Cx43 co-localized with the constituent lysosomal protein, LAMP-2 (Fig. 3, A-C) , and the resident Golgi protein, giantin (Fig. 3, D-F) .
Cx43 Mutants Failed to Form Functional Gap Junction Channels when Expressed in N2A Cells-To determine whether the Cx43 mutants were able to form gap junction channels, GFP-tagged wild-type and G21R and G138R mutants were expressed in N2A cells. Cell pairs that had clear green plaque-like structures at cell interfaces were selected to perform dual whole-cell voltage clamp experiments, and the junctional conductance was determined. As expected, when Cx43-GFP, G21R-GFP, or G138R-GFP were expressed in N2A cells, they were transported to cell surfaces and formed structures consistent with the appearance of gap junction plaques between cell pairs (Fig. 4, A-C) . Through blind analyses, 92% of cell pairs expressing Cx43-GFP exhibited cell coupling, whereas both mutants showed a complete absence of electrical FIG. 4 . Cx43 mutants assemble into gap junction-like clusters at N2A cell interfaces. GJIC-deficient N2A cells were transfected with cDNA encoding human Cx43-GFP (A), G21R-GFP (B), or G138R-GFP (C). Phase images denote cellular architecture and locations of cell-cell interfaces. Similar to Cx43-GFP, both the G21R and G138R mutants exhibited gap junction-like characteristics at cell-cell interfaces. Bars ϭ 10 m.
TABLE I Cx43 mutants are non-functional when expressed in N2A cells
N2A cells were transfected with cDNA encoding human Cx43-GFP, G21R-GFP, or G138R-GFP, and functional coupling was assessed using the dual whole-cell voltage-clamp technique. Isolated cell pairs that had clear evidence of dense green fluorescent structures at cell-cell interfaces were chosen as candidates for dual whole-cell voltage-clamp analysis. *, gap junction channel number was calculated using Cx43 channel unitary conductance as 100 pS (54 
Cx43 Mutations Linked to ODDD
coupling (Table I) . and microinjected with the gap junction permeable dye, Lucifer yellow (Fig. 5, A-I ). As expected, microinjected NRK cells overexpressing Cx43-GFP, in addition to endogenous Cx43, exhibited a high incidence of dye coupling (97%) consistent with wild-type NRK cells (26) . Conversely, NRK cells expressing either the G21R-GFP or G138R-GFP mutant exhibited a marked decrease in the incidence of dye coupling with neighboring cells (17 and 13%, respectively) ( Table II) , suggesting that both G21R and G138R are functionally dominant when co-expressed with endogenous Cx43.
Cx43 Mutants Exhibited a Dominant-negative Effect on Endogenous Cx43 in NRK Cells
To approximate the ratio of GFP-tagged Cx43 mutants to endogenous Cx43 used to exhibit a dominant-negative effect in NRK cells, transiently transfected cells were immunoblotted for untagged and GFP-tagged Cx43. Quantification of Western blots combined with an evaluation of the transfection efficiency revealed that Cx43 mutants were in 4.0 -5.1-fold excess of endogenous Cx43 (Fig. 5J) .
DISCUSSION
Several studies have characterized the clinical features of ODDD and raised possible mutations linked to this disorder (14, 17) . Recently, ODDD was definitively linked to mutations in the GJA1 gene encoding the gap junction protein, Cx43 (15, 18) , which is crucial for GJIC in normal tissues, particularly during morphogenesis (18, 27, 28) . However, because the specific cellular manifestations of such Cx43 mutants have not yet been established, our studies examined the localization and functional properties of two Cx43 mutants, G21R and G138R.
Four major classes of Cx43 mutations are theoretically possible. The first includes those mutations that have no discernible effect on the normal operation of the gap junction channel, which could effectively be considered benign polymorphisms. The second class includes mutants that continue to assemble into gap junction channels, but with altered properties. For example, several mutant forms of Cx32 associated with Xlinked Charcot-Marie-Tooth disease have been shown to have altered conductance, permeability, or gating properties (29 -31) . In some cases, these could be considered gain-of-function mutations. The third class of mutants could involve altered intracellular transport and assembly as with some Cx32 mutants associated with Charcot-Marie-Tooth disease (32) or Cx26 mutations linked to deafness and skin disease (33) (34) (35) . This class of mutants may in fact be functional if transported to the cell surface in association with wild-type proteins, not unlike mutations of the chloride channel responsible for cystic fibrosis (36) . Finally, mutant forms of connexins may occur that allow the connexin to transport to the cell surface with the channels formed being functionally inactive, likely reflecting improper folding, oligomerization, or defects in hemichannel docking (37) . Collectively, these latter two classifications of mutants would be considered loss-of-function mutations, although the mechanisms involved are quite distinct. Our findings suggest that, although both G21R and G138R mutants appeared to form gap junction-like plaques at the cell surface, neither forms functional channels, consistent with loss-of-function mutations. Furthermore, both mutants have a dominantnegative effect on wild-type Cx43 channels as assessed by impairment of dye transfer. These findings are consistent with what is known about disease-causing mutations in other connexin genes (38) and extend earlier speculations as to how mutations in Cx43 may affect function (18) .
Wild-type Cx43 and the two Cx43 mutants examined in NRK, HeLa, and N2A cells exhibited similar intracellular distribution patterns, with clear evidence of gap junction-like assembly at cell-cell interfaces. However, fewer gap junctionlike structures formed in HeLa and N2A cells than in NRK cells, where endogenous Cx43 was available to potentially cooligomerize with the mutants. Importantly, expression of Cx43 mutants in NRK cells would more closely approximate the situation in ODDD patients, who would be expected to express equal amounts of mutant and wild-type Cx43 (18) . In our studies, it was not possible to obtain an accurate measurement of the ratio of Cx43 mutant to endogenous Cx43 in transient transfections of NRK cells, but based on Western blots and overall mutant Cx43 transfection efficiencies, it is likely that the mutants are expressed in 4 -5-fold excess of endogenous Cx43.
The intracellular distribution of Cx43-GFP, G21R-GFP, and G138R-GFP in Cx43-deficient HeLa cells (likely within inclusion bodies and compartments of the secretory and degradation pathways) is notable and was also observed with untagged Cx43 and mutants, suggesting that this distribution is not linked specifically to any adverse effects of the GFP tag. GFPtagged connexins have been widely reported to be functional with essentially unaltered transport and assembly properties (5, 39 -41) . Subpopulations of wild-type and Cx43 mutants localized to lysosomes and the Golgi apparatus were not unexpected given the role of lysosomes in Cx43 degradation (32, 42, 43) and the relatively short half-life (1.5-3.5 h) of Cx43 (44 -46) requiring continual gap junction formation and turnover. Because patients suffering from ODDD would not be expected to express the mutant in the absence of wild-type Cx43, the sole expression of G21R or G138R in N2A or HeLa cells provides valuable insight into the functional state of the mutant but does not accurately mimic the human disease where the mutant and wild-type forms of the protein are likely expressed in equal amounts.
Double whole-cell patch clamp analysis clearly revealed that, although significant populations of both mutants reached the cell surface and clustered at cell-cell interfaces, neither G21R nor G138R made functional gap junction channels. Moreover, our results show that both the G21R and G138R mutations are sufficiently severe to compromise wild-type Cx43 function. Unfortunately, Cx43 null mice (Gja1 Ϫ /Gja1 Ϫ ) shed little insight into the clinical manifestation of ODDD, as these animals not only have no Cx43 (unlike ODDD patients with 50% wild-type and 50% mutant) but these animals die shortly after birth because of heart malformations (27, 47) . However, Cx43 null mice do exhibit developmental craniofacial defects and delayed ossification not unlike patients with ODDD (48). Importantly heterozygous (Gja1 ϩ /Gja1 Ϫ ) mice show no symptoms resem- Cx43-GFP  35  34  97  G21R-GFP  30  5  17  G138R-GFP  32  4  13 bling ODDD, suggesting that a 50% complement of Cx43 is sufficient to sustain morphogenesis and organ function (47) . If the G21R and G138R mutations cause dominant loss-offunction affecting the wild-type as well as the mutant protein, then why are the symptoms of ODDD not more severe, even life-threatening? As with heterozygous Cx43 null mice, the wild-type allele may prevent the mutation from being lethal. In ODDD patients, a small population of wild-type Cx43 gap junction channels would be predicted to exist between adjacent Cx43-expressing cells due to the random oligomerization of equal pools of wild-type and mutant connexins. Indeed, even in our experiments in which the expression of the mutant protein, driven from a highly active viral CMV promoter, was in excess of wild-type Cx43, NRK cells still maintain basal levels of Cx43-based GJIC. This suggests that ODDD patients are likely able to survive with greatly reduced Cx43-mediated GJIC. In addition, because most cells express more than one member of the connexin family, the severity of the ODDD disease in any given tissue is likely dependent on other co-expressed connexins and the level of GJIC compensation that can be achieved.
Cx43 mutants described in this study have features that are not unlike mutations in other connexins. Several Cx31 missense mutations, including those in the amino terminus and first transmembrane domain, result in an autosomal dominant skin disorder (49) . Consistent with the ODDD-linked Cx43 mutant G21R, these Cx31 mutations did not interfere with Cx31 transport to the cell surface, but the Cx31 G12D mutant did not form functional gap junction channels (49) . In other studies, Martin et al. (50) revealed that a six-amino acid deletion in the intracellular loop of Cx32 associated with a mild phenotype of Charcot-Marie-Tooth disease partially inhibited the oligomerization of this connexin and only reduced its function (50) . In essence, the phenotype of this Cx32 deletion mutant was distinctly different from G138R reported here. The location of the G138R mutation in the cytoplasmic loop region of Cx43 has been reported to be a key domain in pH-regulated gating (21) (22) (23) 51) . However, because this mutation results in a functionally inactive Cx43, the defect is far more severe and appears to extend beyond the regulation of channel gating. In fact, from a very recent study it appears that a wide array of point mutations and motif deletions in the cytoplasmic loop of Cx43, which includes the ODDD-linked mutation at amino acid residue 138, results in a functionally incompetent Cx43 (51) .
In the mouse, Cx43 is critical for normal cellular growth and proliferation in developing bone (48) . In osteoblast-specific Cx43 gene deletion studies, skeletal developmental defects were observed (52) . The mechanism by which Cx43 affects bone development is not well understood, but it is possible that it is related to intercellular calcium signaling (53) . Given the non-functional characteristics of the G21R and G138R mutants, we propose that osteoblasts from ODDD patients are likely to have significantly reduced GJIC that may correlate with decreased endochondral and intramembranous ossification as seen in Cx43 knock-out studies (48) . This may reduce the overall ability of osteoblasts to deposit bone, resulting in bone deformities as observed in ODDD patients. Furthermore, during development, the expression of GJA1 is extensive throughout the craniofacial region and limb buds and somites, which correlates with the pleiotropic phenotype observed in ODDD patients (18) . Consequently, manifestations of ODDD may result from the co-expression and intermixing of wild-type with mutant Cx43 during critical stages of development. Thus, further analysis of the changes of this expression in the course of ODDD would be beneficial to elucidate the progress of the malformations.
Taken together, our results indicate that two ODDD-linked mutants, G21R and G138R, form non-functional gap junction channels at the cell surface and exhibit a dominant-negative effect on endogenous Cx43. Deficiencies in GJIC are a likely mechanistic explanation for the developmental abnormalities observed in ODDD patients.
